We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

15 hedge funds and large institutions have $890K invested in Sonoma Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more capital invested

Capital invested by funds: $473K → $890K (+$417K)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$395K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$128K
3
Citadel Advisors
Citadel Advisors
Florida
+$22.1K
4
Creative Planning
Creative Planning
Kansas
+$22.1K
5
VKH
Virtu KCG Holdings
New York
+$21.2K

Top Sellers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
-$18.7K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5K
3
TRCT
Tower Research Capital (TRC)
New York
-$4K
4
Bank of America
Bank of America
North Carolina
-$2.55K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$352K +$395K +465 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$324K +$128K +151 +54%
BRWA
3
B. Riley Wealth Advisors
Florida
$68K -$18.7K -22 -20%
VKH
4
Virtu KCG Holdings
New York
$36K +$21.2K +25 +114%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$20K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$20K +$22.1K +26 New
Creative Planning
7
Creative Planning
Kansas
$20K +$22.1K +26 New
UBS Group
8
UBS Group
Switzerland
$15K +$12.7K +15 +300%
GW
9
GW & Wade
Massachusetts
$13K +$14.4K +17 New
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$9K +$9.35K +11 +1,100%
Wells Fargo
11
Wells Fargo
California
$5K – – –
Morgan Stanley
12
Morgan Stanley
New York
$3K -$1.7K -2 -33%
Bank of America
13
Bank of America
North Carolina
$2K -$2.55K -3 -60%
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$2K -$1.7K -2 -40%
JFGIW
15
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1K – – –
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
– -$5K -4 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$4K -3 Closed
Citigroup
18
Citigroup
New York
– -$850 -1 Closed
MAS
19
Madden Advisory Services
Florida
– -$1K -1 Closed
NPC
20
National Planning Corporation
California
– -$212 – –

SNOA Hedge Fund Activity: Q1 2015 in Review

15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q1 2015, worth a combined $890K — up 88% from $473K a quarter earlier.

Fund positioning in SNOA was balanced in Q1 2015: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $395K. The largest seller was B. Riley Wealth Advisors, cutting an estimated $18.7K.

  • 15 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $890K of Sonoma Pharmaceuticals stock for Q1 2015, up 88% quarter-over-quarter.
  • 4 funds opened new Sonoma Pharmaceuticals positions in Q1 2015 and 4 closed out, a net change of 0 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q1 2015 was Sabby Management, an estimated $395K added.
  • The largest Sonoma Pharmaceuticals seller in Q1 2015 was B. Riley Wealth Advisors, an estimated $18.7K sold.

Based on aggregated 13F filings for Q1 2015.